| Serial Number | 99180190 |
| Word Mark | CGT 360 |
| Filing Date | Monday, May 12, 2025 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Monday, May 4, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Financial consultation to healthcare providers, namely, providing assistance in managing health care expenses related to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Group financial risk management services, namely, health care expense risk pooling and financial risk management services related to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Providing financial and insurance information and consulting in the fields of insurance and healthcare preferred provider networks relating to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; preferred provider network programs, namely, administration of medical services in the nature of cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies provided through a network of health care providers; Preferred provider network services, namely, administering medical benefits in the nature of cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies provided through a network of health care providers under an insurance plan |
| Pseudo Mark | CGT THREE HUNDRED SIXTY |
| Pseudo Mark | CGT THREE SIX ZERO |
| Goods and Services | Business management and consulting services for the health care industry, namely, business management of cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies for health plans, health insurers, self-funded plans, and reinsurers; Business management and administration in the field of healthcare, namely, development, creation and implementation of health care provider networks in the field of cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Business administration of cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapy programs; Business data analytics services, namely, health data collection and analysis in the nature of data compiling and analyzing to provide information and metrics regarding health insurance claims to help clients forecast outcomes, business risk, and expenses; Data acquisition and collection for insurance services for business purposes; Business research in the field of health care relating to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapy programs; Medical cost management relating to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies. |
| Description of Mark | The mark consists of three irregular quadrilaterals which form a shield design in which the center creates an irregular hexagon and a thick, continuous line is used to outline the object, inside the irregular hexagon are the letters "CGT" centered above the number "360". |
| Goods and Services | Consulting services in the field of medical care, namely, developing medical treatment policies related to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Providing medical information in the field of cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Concierge medical services, namely, personal health care concierge services to guide patients through medical treatments related to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Medical consultations, namely, consulting, advising, and assisting patients and families with navigating the complex healthcare system relating to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Providing information in the field of health care, namely, models of care, medical practice, and health care delivery and outcomes, all relating to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Healthcare services, namely, provision of medical care related to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies provided by a network of providers through an integrated, coordinated model of care delivery, with communication of best practices among the network, and the sharing of quality metrics with participants in the network; Consulting regarding healthcare services provided through an integrated and comprehensive model of care delivery featuring protocols, standards, staff training and education, implementation measures for management, care coordination, and disease management all in the field of cell and gene therapy, solid organ and bone marrow transplants, and other complex medical therapies |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 12, 2025 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 12, 2025 |
| Primary Code | 036 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 12, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Emerging Therapy Solutions, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Bloomington, MN 55425 US |
| Event Date | Event Description |
| Monday, May 12, 2025 | NEW APPLICATION ENTERED |
| Monday, May 12, 2025 | APPLICATION FILING RECEIPT MAILED |
| Sunday, September 21, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sunday, September 21, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, September 25, 2025 | ASSIGNED TO EXAMINER |
| Friday, September 26, 2025 | NON-FINAL ACTION WRITTEN |
| Friday, September 26, 2025 | NON-FINAL ACTION E-MAILED |
| Friday, September 26, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, December 9, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, December 9, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 9, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sunday, March 29, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, April 21, 2026 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Wednesday, April 29, 2026 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Monday, May 4, 2026 | NON-FINAL ACTION WRITTEN |
| Monday, May 4, 2026 | NON-FINAL ACTION E-MAILED |
| Monday, May 4, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |